# Clinical Trial on Remote Ischemic Conditioning and Hypertension（HOPE）

Study · id `cardio:ct-nct03566654` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03566654](<https://clinicaltrials.gov/study/NCT03566654>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03566654

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT03566654. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-30 (actual); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT03566654, source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)
- Started: 2018-08-30 (actual) (ClinicalTrials.gov record NCT03566654, source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03566654, source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03566654, source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03566654, source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03566654-2019-09-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial on Remote Ischemic Conditioning and Hypertension（HOPE）
- Condition: Essential Hypertension
- Intervention (Device): remote ischemic conditioning
- Intervention (Device): ambulatory blood pressure monitoring
- Intervention (Device): Sham remote ischemic conditioning
- Lead sponsor: Ji Xunming,MD,PhD
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Ji Xunming,MD,PhD (`cardio:org-ji-xunming-md-phd`)

## Provenance

Content hash: c00f165710caa8ea9d16a64e1bb8f841f1a270c984fdd080d85b78b8fbbc0794
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
